健世科技-B 09877Prospectus Information

Prospectus Information
IPO Timeline
Broker Results (T-2)
2022-10-06
Some brokers release in afternoon
Grey Market (T-1)
2022-10-07
Afternoon
HKEX Allotment (T-1)
2022-10-07
Evening
Registrar Allotment (T-1)
2022-10-07
Evening
Listing Day (T)
2022-10-10
First day of trading
Company Overview
Stock Name健世科技-B
Stock Code09877
Company Full Name健世科技-B
Industry醫療保健
Principal Activities主要在中國從事開發用於治療結構性心臟病的介入產品。
Listing Date2022-10-10
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國浙江省寧波市杭州灣新區濱海四路777號B區5號樓
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://www.jenscare.com/investor
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data
Offering Information
Offering Mechanism To be extracted
Offer PriceHK$ 27.80 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)
Cornerstone Share69.9%
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 22,462,400
Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 1 HK$ 28
200 lots 200 HK$ 5,560
400 lots 400 HK$ 11,120
600 lots 600 HK$ 16,680
800 lots 800 HK$ 22,240
1,000 lots 1,000 HK$ 27,800
1,200 lots 1,200 HK$ 33,360
1,294 lots 1,294 HK$ 35,973
1,400 lots 1,400 HK$ 38,920
1,600 lots 1,600 HK$ 44,480
1,800 lots 1,800 HK$ 50,040
2,000 lots 2,000 HK$ 55,600
3,000 lots 3,000 HK$ 83,400
4,000 lots 4,000 HK$ 111,200
5,000 lots 5,000 HK$ 139,000
6,000 lots 6,000 HK$ 166,800
7,000 lots 7,000 HK$ 194,600
8,000 lots 8,000 HK$ 222,400
10,000 lots 10,000 HK$ 278,000
50,000 lots 50,000 HK$ 1,390,000
160,000 lots 160,000 HK$ 4,448,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
404,000 lots 404,000 HK$ 11,231,200
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)To be extracted
P/E RatioTo be extracted
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 28.25
First Day OpenHK$ 28.0
First Day Change1.62%
First Day Volume1466000.0
First Day Turnover41947900.0
Use of Proceeds
Use of Proceeds1、約65.0%或約100.6百萬港元將分配予我們核心產品(即LuX-Valve及KenValve)的研發、制造及商業化; 2、約25.0%或約38.7百萬港元將分配予產品管線的其他在研產品(包括LuXValve Plus、KenFlex及二尖瓣產品)的研發、臨床試驗及產品注冊; 3、約10.0%或約15.5百萬港元將用于營運資金及一般企業用途。
Underwriting Syndicate
Joint Sponsors (2)
中国国际金融香港证券有限公司 CE AEN894 花旗环球金融亚洲有限公司 CE AAA137
Overall Coordinators (4)
中国国际金融香港证券有限公司 CE AEN894 花旗环球金融亚洲有限公司 CE AAA137 华泰金融控股(香港)有限公司 CE AOK809 农银国际证券有限公司 CE ACX411
Joint Bookrunners (7)
中国国际金融香港证券有限公司 CE AEN894 花旗环球金融亚洲有限公司 CE AAA137 华泰金融控股(香港)有限公司 CE AOK809 农银国际证券有限公司 CE ACX411 交银国际证券有限公司 CE APJ121 富途证券国际(香港)有限公司 CE AZT137 老虎证券(香港)环球有限公司 CE BMU940
Joint Lead Managers (8)
中国国际金融香港证券有限公司 CE AEN894 花旗环球金融亚洲有限公司 CE AAA137 华泰金融控股(香港)有限公司 CE AOK809 农银国际证券有限公司 CE ACX411 交银国际证券有限公司 CE APJ121 富途证券国际(香港)有限公司 CE AZT137 老虎证券(香港)环球有限公司 CE BMU940 元库证券有限公司 CE BLN458
Cornerstone Investors
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 先健科技公司 156,975,480 HKD 69.91% 6 months 2023-04-10
Directors & Management
Chairman呂世文
Company Secretary李遠源
No director data available.
Major Shareholders
Major Shareholders & Holdings呂世文及關連人士(36.03%);李輝及關連人士(14.49%);潘斐及關連人士(7.85%);高瓴資本管理有限公司(5.21%)
Subscription Tiers
IPO Timeline
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics